. . . . . . . . . "Talbutal binds at a distinct binding site associated with a Cl^- ionopore at the GABA_A receptor, increasing the duration of time for which the Cl^- ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged."@en . . "Symptoms of acute barbiturate poisoning include drowsiness, confusion, coma, respiratory depression, hypotension, and shock."@en . . . . "Lotusate"@en . "Talbutal, also called 5-allyl-5-sec-butylbarbituric acid, is a barbiturate with a short to intermediate duration of action. Talbutal is a schedule III drug in the U.S."@en . . "Talbutale"@en . . . . . . "approved"@en . "illicit"@en . . . . "115-44-6"@en . . . . . "sec-Butyl allyl barbituric acid"@en . . . . "5-allyl-5-sec-butylbarbituric acid"@en . . . . "Talbutal"@en . . "Talbutalum"@en . "(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione"@en . . . "For use as a sedative and hypnotic."@en . . "Humans and other mammals"@en . . . .